首页 > 最新文献

medRxiv - Otolaryngology最新文献

英文 中文
Hearing Progression of Children with Enlarged Vestibular Aqueduct (EVA) According to SLC26A4 Genetic Mutation Status 根据SLC26A4基因突变状态对前庭导水管增大儿童听力进展的影响
Pub Date : 2023-11-30 DOI: 10.1101/2023.11.29.23299192
Madeline Hocking Osborne, Margaret Koeritzer, Hannah Herd, Melissa Jane Polonenko
Enlarged vestibular aqueduct (EVA) is a malformation associated with sensorineural hearing loss in children. Mutations in the SLC26A4 gene are also associated with EVA and may contribute to more severe hearing losses that progress, but the timescale of this progression remains unknown. Given that children undergo significant speech and language development, a better understanding of the timing and extent of hearing loss is needed for individuals who have EVA. Through a retrospective review of records in a local database, we aimed to 1) estimate the prevalence of a SLC26A4 mutation in this pediatric EVA cohort; and 2) compare hearing threshold severity and timing of progression across children who have EVA and different SLC26A4 statuses. Of 62 children with EVA, 39 had available genetic results and of these, 15 had at least one mutation of the SLC26A4 gene (38%). The children with a SLC26A4 mutation had a more severe onset of hearing loss and a more rapid progression of hearing loss over time, especially for higher frequencies, than children without a mutation in this gene. This longitudinal information may facilitate prognostic counseling to pediatric patients and better inform the audiology follow-up appointments for these families.
增大的前庭导水管(EVA)是一种与儿童感音神经性听力损失相关的畸形。SLC26A4基因的突变也与EVA有关,并可能导致更严重的听力损失,但这种进展的时间尺度仍不清楚。考虑到儿童经历了重要的言语和语言发展,对于患有EVA的人来说,更好地了解听力损失的时间和程度是必要的。通过对当地数据库记录的回顾性分析,我们的目的是:1)估计SLC26A4突变在该儿童EVA队列中的患病率;2)比较EVA和不同SLC26A4状态儿童的听力阈值严重程度和进展时间。在62例EVA患儿中,39例有可用的遗传结果,其中15例至少有一个SLC26A4基因突变(38%)。SLC26A4基因突变的儿童与没有该基因突变的儿童相比,听力损失的发病更严重,随着时间的推移,听力损失的进展更快,特别是对于频率较高的儿童。这种纵向信息可以促进对儿童患者的预后咨询,并更好地为这些家庭的听力学随访预约提供信息。
{"title":"Hearing Progression of Children with Enlarged Vestibular Aqueduct (EVA) According to SLC26A4 Genetic Mutation Status","authors":"Madeline Hocking Osborne, Margaret Koeritzer, Hannah Herd, Melissa Jane Polonenko","doi":"10.1101/2023.11.29.23299192","DOIUrl":"https://doi.org/10.1101/2023.11.29.23299192","url":null,"abstract":"Enlarged vestibular aqueduct (EVA) is a malformation associated with sensorineural hearing loss in children. Mutations in the <em>SLC26A4</em> gene are also associated with EVA and may contribute to more severe hearing losses that progress, but the timescale of this progression remains unknown. Given that children undergo significant speech and language development, a better understanding of the timing and extent of hearing loss is needed for individuals who have EVA. Through a retrospective review of records in a local database, we aimed to 1) estimate the prevalence of a <em>SLC26A4</em> mutation in this pediatric EVA cohort; and 2) compare hearing threshold severity and timing of progression across children who have EVA and different <em>SLC26A4</em> statuses. Of 62 children with EVA, 39 had available genetic results and of these, 15 had at least one mutation of the <em>SLC26A4</em> gene (38%). The children with a <em>SLC26A4</em> mutation had a more severe onset of hearing loss and a more rapid progression of hearing loss over time, especially for higher frequencies, than children without a mutation in this gene. This longitudinal information may facilitate prognostic counseling to pediatric patients and better inform the audiology follow-up appointments for these families.","PeriodicalId":501185,"journal":{"name":"medRxiv - Otolaryngology","volume":"243 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138510808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the audiological knowledge of three chatbots – ChatGPT, Bing Chat, and Bard 三种聊天机器人——ChatGPT、Bing Chat和Bard的听力学知识比较
Pub Date : 2023-11-22 DOI: 10.1101/2023.11.22.23298893
W. Wiktor Jedrzejczak, Krzysztof Kochanek
Objective The purpose of this study was to evaluate three chatbots – OpenAI ChatGPT, Microsoft Bing Chat, and Google Bard – in terms of their responses to a defined set of audiological questions.
本研究的目的是评估三个聊天机器人——OpenAI ChatGPT、微软Bing Chat和谷歌Bard——对一组定义的听力学问题的回答。
{"title":"Comparison of the audiological knowledge of three chatbots – ChatGPT, Bing Chat, and Bard","authors":"W. Wiktor Jedrzejczak, Krzysztof Kochanek","doi":"10.1101/2023.11.22.23298893","DOIUrl":"https://doi.org/10.1101/2023.11.22.23298893","url":null,"abstract":"<strong>Objective</strong> The purpose of this study was to evaluate three chatbots – OpenAI ChatGPT, Microsoft Bing Chat, and Google Bard – in terms of their responses to a defined set of audiological questions.","PeriodicalId":501185,"journal":{"name":"medRxiv - Otolaryngology","volume":"258 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138510806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Audiovestibular adverse events following COVID-19 vaccinations COVID-19疫苗接种后的听觉前庭不良事件
Pub Date : 2023-11-22 DOI: 10.1101/2023.11.13.23298435
Aishwarya N Shetty, Hannah J Morgan, Linny K Phuong, John Mallard, Diana Vlasenko, Christopher Pearce, Nigel W Crawford, Jim P Buttery, Hazel J Clothier
Importance Evidence regarding audiovestibular adverse events post COVID-19 vaccination to date has been inconclusive regarding a potential etiological association. This study used a multi-data source approach to assess incidence of these events following COVID-19 vaccination.
迄今为止,关于COVID-19疫苗接种后听觉前庭不良事件的证据尚未确定是否存在潜在的病因学关联。本研究采用多数据源方法评估COVID-19疫苗接种后这些事件的发生率。
{"title":"Audiovestibular adverse events following COVID-19 vaccinations","authors":"Aishwarya N Shetty, Hannah J Morgan, Linny K Phuong, John Mallard, Diana Vlasenko, Christopher Pearce, Nigel W Crawford, Jim P Buttery, Hazel J Clothier","doi":"10.1101/2023.11.13.23298435","DOIUrl":"https://doi.org/10.1101/2023.11.13.23298435","url":null,"abstract":"<strong>Importance</strong> Evidence regarding audiovestibular adverse events post COVID-19 vaccination to date has been inconclusive regarding a potential etiological association. This study used a multi-data source approach to assess incidence of these events following COVID-19 vaccination.","PeriodicalId":501185,"journal":{"name":"medRxiv - Otolaryngology","volume":"121 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138510819","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of Chronic Rhinosinusitis in Rajavithi hospital workers, Bangkok, Thailand 泰国曼谷Rajavithi医院工作人员慢性鼻窦炎患病率
Pub Date : 2023-07-26 DOI: 10.1101/2023.07.20.23292827
Wirach Chitsuthipakorn, Suphitsara Naphapunsakul, Patlada Korwattanamongkol, Kittichai Mongkolkul, Somjin Chindavijak
Background: The prevalence of chronic rhinosinusitis (CRS) has been reported to range from 5% to 12% in different parts of the world. However, the prevalence of CRS in Thailand has not been investigated. Our objective was to determine the prevalence of CRS among hospital workers and identify any potential problems encountered during the survey.Methods: Adult workers (>18 years) of Rajavithi Hospital, a tertiary hospital in Bangkok, Thailand, were recruited. This cross-sectional survey was conducted from September 2021 to September 2022. The participants were given a link to online questionnaires asking if they had nasal obstruction, discharge, decreased smell sensation, or facial pain and their respective duration. Phone numbers and email were asked for contact when needed. The participants who fulfilled the symptom and duration according to the European position paper on rhinosinusitis and nasal polyp 2020 were counted as symptom-based CRS patients. These patients were then contacted for nasal endoscopy. The endoscopic-based diagnosis of CRS was made after positive endoscopy findings. Result: A total of 1,025 participants (mean age of 33.7 years) were recruited. Of total, there were 34 (3.3%) and 6 (0.58%) participants fulfilled symptom- and endoscopy-based diagnoses, respectively. Fourteen participants did not respond to calls or emails. Five patients refused to visit the clinic due to inconveniences. One patient refused nasal endoscopy because of the expenses. Conclusion: The overall prevalence of chronic rhinosinusitis in workers of Rajavithi Hospital, was 3.3% and 0.58% by symptom- and endoscopy-based criteria, respectively. Difficulty reaching the participants for nasal endoscopy was the leading survey problem.
背景:据报道,慢性鼻窦炎(CRS)的患病率在世界不同地区从5%到12%不等。然而,CRS在泰国的流行情况尚未调查。我们的目的是确定CRS在医院工作人员中的患病率,并确定在调查过程中遇到的任何潜在问题。方法:招募泰国曼谷三级医院Rajavithi医院的成年工作人员(18岁)。这项横断面调查于2021年9月至2022年9月进行。参与者获得了一个在线问卷的链接,询问他们是否有鼻塞、流涕、嗅觉减退或面部疼痛,以及它们各自的持续时间。电话号码和电子邮件被要求在需要时联系。根据欧洲鼻窦炎和鼻息肉立场文件2020,满足症状和持续时间的参与者被计算为基于症状的CRS患者。这些患者随后接受鼻内窥镜检查。在内镜检查结果呈阳性后,对CRS进行基于内镜的诊断。结果:共招募了1025名参与者(平均年龄33.7岁)。总共有34名(3.3%)和6名(0.58%)参与者分别完成了基于症状和基于内窥镜的诊断。14名参与者没有回复电话或电子邮件。5名患者因不便拒绝就诊。一位患者因为费用问题拒绝接受鼻内窥镜检查。结论:以症状和内窥镜为标准,Rajavithi医院工作人员慢性鼻窦炎的总体患病率分别为3.3%和0.58%。难以接触到参与者进行鼻内窥镜检查是调查的主要问题。
{"title":"Prevalence of Chronic Rhinosinusitis in Rajavithi hospital workers, Bangkok, Thailand","authors":"Wirach Chitsuthipakorn, Suphitsara Naphapunsakul, Patlada Korwattanamongkol, Kittichai Mongkolkul, Somjin Chindavijak","doi":"10.1101/2023.07.20.23292827","DOIUrl":"https://doi.org/10.1101/2023.07.20.23292827","url":null,"abstract":"Background: The prevalence of chronic rhinosinusitis (CRS) has been reported to range from 5% to 12% in different parts of the world. However, the prevalence of CRS in Thailand has not been investigated. Our objective was to determine the prevalence of CRS among hospital workers and identify any potential problems encountered during the survey.\u0000Methods: Adult workers (&gt;18 years) of Rajavithi Hospital, a tertiary hospital in Bangkok, Thailand, were recruited. This cross-sectional survey was conducted from September 2021 to September 2022. The participants were given a link to online questionnaires asking if they had nasal obstruction, discharge, decreased smell sensation, or facial pain and their respective duration. Phone numbers and email were asked for contact when needed. The participants who fulfilled the symptom and duration according to the European position paper on rhinosinusitis and nasal polyp 2020 were counted as symptom-based CRS patients. These patients were then contacted for nasal endoscopy. The endoscopic-based diagnosis of CRS was made after positive endoscopy findings. Result: A total of 1,025 participants (mean age of 33.7 years) were recruited. Of total, there were 34 (3.3%) and 6 (0.58%) participants fulfilled symptom- and endoscopy-based diagnoses, respectively. Fourteen participants did not respond to calls or emails. Five patients refused to visit the clinic due to inconveniences. One patient refused nasal endoscopy because of the expenses. Conclusion: The overall prevalence of chronic rhinosinusitis in workers of Rajavithi Hospital, was 3.3% and 0.58% by symptom- and endoscopy-based criteria, respectively. Difficulty reaching the participants for nasal endoscopy was the leading survey problem.","PeriodicalId":501185,"journal":{"name":"medRxiv - Otolaryngology","volume":"245 ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2023-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138510807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
medRxiv - Otolaryngology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1